Research Article
Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma
Ingunn M. Stromnes, Adam L. Burrack, Ayaka Hulbert, Patrick Bonson, Cheryl Black, J. Scott Brockenbrough, Jackson F. Raynor, Ellen J. Spartz, Robert H. Pierce, Philip D. Greenberg and Sunil R. Hingorani
Ingunn M. Stromnes
Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, Minnesota.
Adam L. Burrack
Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.
Ayaka Hulbert
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Patrick Bonson
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Cheryl Black
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
J. Scott Brockenbrough
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Jackson F. Raynor
Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.
Ellen J. Spartz
Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, Minnesota.
Robert H. Pierce
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Philip D. Greenberg
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington.Division of Medical Oncology, University of Washington School of Medicine, Seattle, Washington.
Sunil R. Hingorani
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.Division of Medical Oncology, University of Washington School of Medicine, Seattle, Washington.Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
DOI: 10.1158/2326-6066.CIR-18-0448

Article Figures & Data
Additional Files
Supplementary Data
- Supplementary Figures 1-4 - Supplementary Figures 1-4
Published OnlineFirst May 3, 2019
doi: 10.1158/2326-6066.CIR-18-0448
Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma
Ingunn M. Stromnes, Adam L. Burrack, Ayaka Hulbert, Patrick Bonson, Cheryl Black, J. Scott Brockenbrough, Jackson F. Raynor, Ellen J. Spartz, Robert H. Pierce, Philip D. Greenberg and Sunil R. Hingorani
Cancer Immunol Res May 3 2019 DOI: 10.1158/2326-6066.CIR-18-0448
Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma
Ingunn M. Stromnes, Adam L. Burrack, Ayaka Hulbert, Patrick Bonson, Cheryl Black, J. Scott Brockenbrough, Jackson F. Raynor, Ellen J. Spartz, Robert H. Pierce, Philip D. Greenberg and Sunil R. Hingorani
Cancer Immunol Res May 3 2019 DOI: 10.1158/2326-6066.CIR-18-0448
Jump to section
Advertisement